Volume 17, Number 10—October 2011
Dispatch
Antimicrobial Ointments and Methicillin-Resistant Staphylococcus aureus USA300
Table 1
Source | Outpatients | Inpatients | Health care workers | |||
No. community-acquired infections* | No. hospital-acquired infections | No. community-acquired infections* | No. hospital-acquired infections | |||
Skin and soft tissue | 23 | 7 | 4 | 23 | 0 | |
Bloodstream | 0 | 2 | 1 | 19 | 0 | |
Respiratory tract | 0 | 2 | 1 | 17 | 0 | |
Urinary tract | 0 | 2 | 2 | 3 | 0 | |
Ear | 8 | 0 | 0 | 1 | 0 | |
Eye | 3 | 0 | 0 | 3 | 0 | |
Others | 1 | 1 | 2 | 3 | 0 | |
Carriage | 14 | 10 | 3 | 29 | 0 | |
Screening | 50 | 0 | 2 | 20 | 3 | |
Total | 99 | 24 | 15 | 118 | 3
*Community-acquired infections were determined on the basis of patients’ histories according to Centers for Disease Control and Prevention (Atlanta, GA, USA) guidelines (www.cdc.gov/mrsa/diagnosis/index.html). *Community-acquired infections were determined on the basis of patients’ histories according to Centers for Disease Control and Prevention (Atlanta, GA, USA) guidelines (www.cdc.gov/mrsa/diagnosis/index.html). *Community-acquired infections were determined on the basis of patients’ histories according to Centers for Disease Control and Prevention (Atlanta, GA, USA) guidelines (www.cdc.gov/mrsa/diagnosis/index.html). *Community-acquired infections were determined on the basis of patients’ histories according to Centers for Disease Control and Prevention (Atlanta, GA, USA) guidelines (www.cdc.gov/mrsa/diagnosis/index.html). |
*Community-acquired infections were determined on the basis of patients’ histories according to Centers for Disease Control and Prevention (Atlanta, GA, USA) guidelines (www.cdc.gov/mrsa/diagnosis/index.html).